SUDOGEST NASAL DECONGESTANT
- Product NDC
- 50090-4345
- 11-digit product format
- 500904345
- Labeler code
- 50090
- Product ID
- 50090-4345_72064c3e-8348-4230-b2e3-47a03e3467df
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Pseudoephedrine HCl
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 1991-09-10
- Substance
- PSEUDOEPHEDRINE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50090-4345 | 50090-4345-0 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 50090-4345 | 50090-4345-2 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 50090-4345 | 50090-4345-3 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 50090-4345 | 50090-4345-4 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 50090-4345 | 50090-4345-5 | D | Discontinued by firm | 2026-10-23 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50090-4345-4 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50090-4345-3 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50090-4345-2 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50090-4345-5 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50090-4345-0 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50090-4345-4 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50090-4345-3 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50090-4345-2 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50090-4345-5 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50090-4345-0 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 50090-4345-4 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 50090-4345-3 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 50090-4345-2 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 50090-4345-5 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 50090-4345-0 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 50090-4345-4 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 50090-4345-3 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 50090-4345-2 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 50090-4345-5 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 50090-4345-0 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 50090-4345-4 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 50090-4345-3 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 50090-4345-2 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 50090-4345-5 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 50090-4345-0 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 50090-4345-4 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 50090-4345-3 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 50090-4345-2 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 50090-4345-5 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 50090-4345-0 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 50090-4345-4 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 50090-4345-3 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 50090-4345-2 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 50090-4345-5 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 50090-4345-0 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 50090-4345-4 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 50090-4345-3 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 50090-4345-2 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 50090-4345-5 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 50090-4345-0 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 50090-4345-4 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 50090-4345-3 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 50090-4345-2 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 50090-4345-5 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 50090-4345-0 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 50090-4345-4 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 50090-4345-3 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 50090-4345-2 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 50090-4345-5 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 50090-4345-0 | ad56d346431e… | cc804d4bbf1e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SUDOGEST NASAL DECONGESTANT
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PSEUDOEPHEDRINE HYDROCHLORIDE | 30 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6V9V2RYJ8N | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 09feb5f0-c22d-4a1b-97a0-d5767e5f7730 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| e974e22d-8688-7d92-1e87-40c1079e170c | Product name | 3 | 20151125 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 30c51294-7ae9-8007-7de6-58222684a0be | Product name | 1 | 20140508 |
| 4f26f669-fc6c-40ef-9e26-1c7b2390ee66 | Product name | 1 | 20140508 |
| 70a83adc-6047-bbea-5a08-dfd304aa47d2 | Product name | 1 | 20140508 |
| 858ce051-9941-aafc-8c7c-44a8e0227463 | Product name | 1 | 20140508 |
| b893258d-0942-3d8a-3411-056ea0788ff5 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-4345-0 | 2023-02-07 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-1 | 2023-02-07 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-2 | 2023-02-07 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-3 | 2023-02-07 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-4 | 2023-02-07 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-5 | 2023-02-07 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-0 | 2023-01-30 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-1 | 2023-01-30 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-2 | 2023-01-30 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-3 | 2023-01-30 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-4 | 2023-01-30 | SUDOGEST NASAL DECONGESTANT |
| 50090-4345-5 | 2023-01-30 | SUDOGEST NASAL DECONGESTANT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4345-0 | SUDOGEST NASAL DECONGESTANT | 48 in 1 BOTTLE | TABLET, FILM COATED | 48 | 10 | |
| 50090-4345-1 | SUDOGEST NASAL DECONGESTANT | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 10 | |
| 50090-4345-1 | SUDOGEST NASAL DECONGESTANT | 24 in 1 CARTON | TABLET, FILM COATED | 24 | 10 | |
| 50090-4345-2 | SUDOGEST NASAL DECONGESTANT | 12 in 1 BOTTLE | TABLET, FILM COATED | 12 | 10 | |
| 50090-4345-3 | SUDOGEST NASAL DECONGESTANT | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 10 | |
| 50090-4345-4 | SUDOGEST NASAL DECONGESTANT | 4 in 1 BOTTLE | TABLET, FILM COATED | 4 | 10 | |
| 50090-4345-5 | SUDOGEST NASAL DECONGESTANT | 15 in 1 BOTTLE | TABLET, FILM COATED | 15 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4345-1 | EA - Each | 50090-4345 | a510bcc2-0b21-485b-b9e5-434600a49171 | 1 | 2022-09-12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4345 | SUDOGEST NASAL DECONGESTANT (PSEUDOEPHEDRINE HCL) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 10 | Current NDC, Legacy NDC, 7 package rows | 20241109_09feb5f0-c22d-4a1b-97a0-d5767e5f7730.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night | ASPIRIN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE BITARTRATE | Bayer HealthCare LLC. | fc60af2f-83cb-99ea-e053-6394a90a0b3b | 2026-01-08 | Warnings | M012 |
| Alka Seltzer Plus Maximum Strength Sinus, Allergy And Cough Power Max Gels | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE , DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE | Bayer HealthCare LLC. | e17eb929-209d-a2d1-e053-2a95a90a4cf3 | 2026-01-08 | Warnings | M012 |
| Alka-Seltzer Plus Severe Cold Night PowerFast Fizz | ASPIRIN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE BITARTRATE | Bayer HealthCare LLC. | c1fae6c7-bbac-1320-e053-2a95a90aac5a | 2026-01-08 | Warnings | M012 |
| Alka-Seltzer Plus Night Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | Bayer HealthCare LLC. | f4c60ca1-ba59-4a92-84a5-6ba65faa56ab | 2026-01-08 | Warnings | M012 |
| Alka-Seltzer Plus Day Severe Cold Plus Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Bayer HealthCare LLC. | cec51eab-cce3-4965-a14e-a46d953050c4 | 2026-01-08 | Warnings | M012 |
| VanaCof 2 | CHLOPHEDIANOL HCL, DEXCHLORPHENIRAMINE MALEATE | GM Pharmaceuticals, INC | 0c7c6756-abb2-c10c-e063-6394a90a9863 | 2026-01-08 | Warnings | M012 |
| VANACOF XP Cough / Chest Congestion | DEXTROMETHORPHAN HBR, GUAIFENESIN | GM Pharmaceuticals, INC | 0b3a8cc1-a49f-e1e5-e063-6394a90a1c06 | 2026-01-08 | Warnings | M012 |
| Diphenhydramine HCl | DIPHENHYDRAMINE HCL | INVAHEALTH INC | e4e4004f-77e3-569d-e053-2a95a90a73fe | 2026-01-08 | Warnings | M012 |
| Robitussin Maximum Strength Cough Plus Chest Congestion DM | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | Haleon US Holdings LLC | 868ac65a-63e2-46ac-b87d-66b289086756 | 2026-01-08 | Warnings | M012 |
| Theraflu Flu Relief Max Strength Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | Haleon US Holdings LLC | 0324195f-506d-4747-990e-ad44e2a117d9 | 2026-01-07 | Warnings | M012 |
| Sambrosa Night | DOXYLAMINE SUCCINATE | Sambrosa Care, Inc. | acdc8740-6231-d1e8-e053-2995a90a3b8d | 2026-01-07 | Warnings | M012 |
| VAPOREX | CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, AND MENTHOL | DLC Laboratories, Inc. | 971943b1-4199-4f75-9d2d-61242d346b5f | 2026-01-07 | Warnings | M012 |
| BACTIMICINA COUGH AND COLD | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | DLC Laboratories, Inc. | 2e612c62-9bbb-45f2-a253-aa2bfaeaac70 | 2026-01-07 | Warnings | M012 |
| Earths Care Chest Rub | CAMPHOR, EUCALYPTUS OI, MENTHOL | DLC Laboratories, Inc | 2424f5d5-1772-96f1-e063-6294a90a89ee | 2026-01-07 | Warnings | M012 |
| Bactimicina Vapor Rub | VAPOR RUB | DLC Laboratories, Inc. | 176b617a-faf6-7893-e063-6294a90a046b | 2026-01-07 | Warnings | M012 |
| Sinus Pressure and Pain | ACETAMINOPHEN, PHENYLEPHRINE HCL | Family Dollar Services Inc | 0d3e4ceb-5059-4aac-8aa2-bf714ca9deb2 | 2026-01-07 | Warnings | M012 |
| Tussin Multi Symptom Cold CF | DEXTROMETHORPHAN HBR GUAIFENESIN PHENYLEPHRINE HCL | QUALITY CHOICE (Chain Drug Marketing Association) | b225e897-5728-4519-b727-c0f361c75976 | 2026-01-07 | Warnings | M012 |
| Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Walgreen Company | 80b218f7-66bb-4e15-a0dc-ec9b6af1b056 | 2026-01-07 | Warnings | M012 |
| tussin cough and chest congestion | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Rite Aid Corporation | 13618054-d0c5-4190-b626-e7e91b855738 | 2026-01-06 | Warnings | M012 |
| Berkley and Jensen Tussin DM Max | DEXTROMETHORPHAN HBR, GUAIFENESIN | BJWC | c15b97a8-968f-4d38-905e-863e9fd16ce6 | 2026-01-06 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1049160 | pseudoephedrine HCl 30 MG Oral Tablet | PSN | 09feb5f0-c22d-4a1b-97a0-d5767e5f7730 | 10 |
| 1049162 | SudoGest 30 MG Oral Tablet | PSN | 09feb5f0-c22d-4a1b-97a0-d5767e5f7730 | 10 |
| 1049162 | pseudoephedrine hydrochloride 30 MG Oral Tablet [Sudogest] | SBD | 09feb5f0-c22d-4a1b-97a0-d5767e5f7730 | 10 |
| 1049160 | pseudoephedrine hydrochloride 30 MG Oral Tablet | SCD | 09feb5f0-c22d-4a1b-97a0-d5767e5f7730 | 10 |
| 1049162 | Sudogest 30 MG Oral Tablet | SY | 09feb5f0-c22d-4a1b-97a0-d5767e5f7730 | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-4345-0 | 50090434500 | 48 TABLET, FILM COATED in 1 BOTTLE (50090-4345-0) | 2019-10-09 | 0000-00-00 | No | No | Current | |
| 50090-4345-1 | 50090434501 | 24 BLISTER PACK in 1 CARTON (50090-4345-1) / 1 TABLET, FILM COATED in 1 BLISTER PACK | 24 blister pack | 2019-06-10 | 0000-00-00 | No | No | Current |
| 50090-4345-2 | 50090434502 | 12 TABLET, FILM COATED in 1 BOTTLE (50090-4345-2) | 2019-10-09 | 0000-00-00 | No | No | Current | |
| 50090-4345-3 | 50090434503 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-4345-3) | 2019-10-09 | 0000-00-00 | No | No | Current | |
| 50090-4345-4 | 50090434504 | 4 TABLET, FILM COATED in 1 BOTTLE (50090-4345-4) | 2019-10-09 | 0000-00-00 | No | No | Current | |
| 50090-4345-5 | 50090434505 | 15 TABLET, FILM COATED in 1 BOTTLE (50090-4345-5) | 2019-10-09 | 0000-00-00 | No | No | Current |